Sen. Grassley on importation
Executive Summary
Sen. Chuck Grassley (R-Iowa) expresses optimism that a drug importation bill will pass Senate in 2004. The result may be "a little less money for research for our pharmaceuticals, but why wouldn't we expect [manufacturers] to sell their drugs a little bit higher to German or Canadian consumers?" he asks during the Joint National Government Affairs Advertising Conference in Washington, D.C. April 28. Senate Health Committee plans to hold hearings on importation in May (1"The Pink Sheet" April 26, 2004, p. 19)...
You may also be interested in...
Senate Drug Import Bill Would Require Notice Of Manufacturing Changes
Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.